Succinylcholine for Emergency Airway Rescue in Class B Ambulatory Facilities: The Society for Ambulatory Anesthesia Position Statement

Anesth Analg. 2017 May;124(5):1447-1449. doi: 10.1213/ANE.0000000000001682.

Abstract

Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedative-hypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine-triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.

MeSH terms

  • Airway Management / adverse effects
  • Airway Management / methods*
  • Ambulatory Care / statistics & numerical data*
  • Ambulatory Care Facilities
  • Anesthesia*
  • Dantrolene / adverse effects
  • Dantrolene / therapeutic use
  • Emergency Medical Services
  • Humans
  • Laryngismus / drug therapy
  • Laryngismus / mortality*
  • Malignant Hyperthermia / mortality*
  • Muscle Relaxants, Central / adverse effects
  • Muscle Relaxants, Central / therapeutic use
  • Neuromuscular Depolarizing Agents / adverse effects*
  • Perioperative Care
  • Prevalence
  • Succinylcholine / adverse effects*

Substances

  • Muscle Relaxants, Central
  • Neuromuscular Depolarizing Agents
  • Dantrolene
  • Succinylcholine